stsa-1301
Botanicalexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 21, 2023 (NCT06148389)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06929299 | Phase 1/Phase 2 (Phase 2) | May 12, 2025 | Chinese Academy of Medical Sciences, Government of China, Peking University |
| NCT06148389 | Phase 1 | Nov 21, 2023 | Capital Medical University, Staidson (Beijing) Biopharmaceuticals Co., Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Government of China | Government | 1 | 1 | 1 | 2025 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Staidson (Beijing) Biopharmaceuticals Co., Ltd | For profit | 1 | 1 | 1 | 2023 |
5 organizations
Page 1 / 1